Z. Hrušková

发表

Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis

V. Tesar, M. Tóthová, Z. Hruskova, 2023, Frontiers in Cardiovascular Medicine.

Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients.

V. Tesar, L. Kovarova, Z. Hruskova, 2021, International journal of cardiology.

Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis.

V. Tesar, J. Závada, R. Pytlík, 2009, Rheumatology.

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

V. Tesar, J. Levy, C. Pusey, 2017, Kidney international.

Genetically distinct subsets within ANCA-associated vasculitis.

Panos Deloukas, Bo Baslund, Mårten Segelmark, 2012, The New England journal of medicine.

Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis

L. Gesualdo, V. Tesar, D. Jayne, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients

E. Havrdová, D. Horáková, T. Uher, 2017, BMC Neurology.

Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases

T. Zima, M. Lukáš, Z. Hruskova, 2011, Autoimmune diseases.

Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.

C. Wanner, P. Ravani, V. Tesar, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Lessons learned from the failure of several recent trials with biologic treatment in systemic lupus erythematosus

V. Tesar, Z. Hruskova, Z. Hrušková, 2018, Expert opinion on biological therapy.

Lupus Nephritis: A Different Disease in European Patients?

V. Tesar, Z. Hruskova, Z. Hrušková, 2015, Kidney Diseases.

Understanding Histolopathologic Characteristics to Predict Renal Outcomes in Lupus Nephritis.

Vladimir Tesar, V. Tesar, Z. Hruskova, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Long-term outcome of kidney function in patients with ANCA-associated vasculitis

K. Westman, O. Flossmann, A. Berden, 2024, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Mass spectrometry-based proteomic exploration of the small urinary extracellular vesicles in ANCA-associated vasculitis in comparison with total urine.

V. Tesar, T. Zima, P. Přikryl, 2020, Journal of proteomics.

Increased Levels of Soluble ST2 in Patients with Active Newly Diagnosed ANCA-Associated Vasculitis

V. Lánská, V. Tesar, C. Edelstein, 2015, Mediators of inflammation.

ANCA-associated renal vasculitis - an update.

V. Tesar, Z. Hruskova, Z. Hrušková, 2013, Contributions to nephrology.

Avacopan in the treatment of ANCA-associated vasculitis

V. Tesar, Z. Hruskova, Z. Hrušková, 2018, Expert opinion on investigational drugs.

Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study.

F. Scolari, V. Tesar, A. Vaglio, 2022, Rheumatology.

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy

V. Tesar, Z. Hruskova, Z. Hrušková, 2021, Frontiers in Immunology.

Rituximab in Membranous Nephropathy

J. Wetzels, V. Tesar, M. Muto, 2021, Kidney international reports.

Rituximab for treatment of severe renal disease in ANCA associated vasculitis

T. Cavero, V. Tesar, D. Jayne, 2016, Journal of Nephrology.

Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives

V. Tesar, O. Slanař, Z. Hruskova, 2022, Frontiers in Immunology.

Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

J. Wetzels, V. Tesar, M. Muto, 2020, Autoimmunity reviews.

Echocardiography in patients with chronic kidney diseases

Z. Hruskova, J. Malík, V. Bednarova, 2018, Cor et Vasa.

Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis

V. Tesar, Z. Hruskova, M. Korabečná, 2022, International journal of molecular sciences.

Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis

V. Tesar, A. Salama, C. Pusey, 2019, The Journal of Rheumatology.

Impact of treatment on damage and hospitalization in elderly patients with microscopic polyangiitis and granulomatosis with polyangiitis Authors

V. Tesar, C. Pusey, A. Bruchfeld, 2020 .

Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study

V. Lánská, V. Tesar, Z. Hruskova, 2016, Arthritis Research & Therapy.

Can adequate treatment influence the postembolization syndrome and cytokine release in patients undergoing iatrogenic renal artery embolization?

V. Tesar, M. Merta, M. Haluzík, 2011, Prague medical report.

Belimumab in the management of systemic lupus erythematosus – an update

V. Tesar, Z. Hruskova, Z. Hrušková, 2017, Expert opinion on biological therapy.

Treatment of Severe Renal Disease in ANCA Positive and Negative Small Vessel Vasculitis with Rituximab

V. Tesar, D. Jayne, D. Geetha, 2015, American Journal of Nephrology.

Matrix Metalloproteinases and Their Tissue Inhibitors: an Evaluation of Novel Biomarkers in ANCA-Associated Vasculitis.

V. Tesar, T. Zima, M. Kalousová, 2019, Folia biologica.

AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats

Z. Hruskova, L. Kopkan, Z. Vaňourková, 2021, Scientific Reports.

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis.

Kenneth G. C. Smith, P. Lyons, V. Tesar, 2017, The Journal of allergy and clinical immunology.

Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

V. Tesar, D. Jayne, P. Seo, 2018, Kidney international reports.

Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis

M. Karsdal, M. Kollár, D. Maixnerova, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complement Inhibition in ANCA-Associated Vasculitis

V. Tesar, Z. Hruskova, Z. Hrušková, 2022, Frontiers in Immunology.